Viewing Study NCT05886634


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2025-12-28 @ 12:04 AM
Study NCT ID: NCT05886634
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2023-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module